Functional MRI for anticancer therapy assessment (Q34975002)

5 August 2017

1 reference

title

Functional MRI for anticancer therapy assessment (English)

1 reference

magnetic resonance imaging

5 August 2017

main subject

0 references

author name string

Padhani AR

series ordinal

1

1 reference

5 August 2017

publication date

1 November 2002

1 reference

European Journal of Cancer

5 August 2017

published in

1 reference

5 August 2017

volume

38

1 reference

5 August 2017

issue

16

1 reference

5 August 2017

page(s)

2116-2127

1 reference

Reporting results of cancer treatment

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Response rate accuracy in oncology trials: reasons for interobserver variability. Groupe Français d'Immunothérapie of the Fédération Nationale des Centres de Lutte Contre le Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

CT estimations of mean attenuation values and volume in testicular tumors: a comparison with surgical and histologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Molecular imaging: exploring the next frontier

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Positron emission tomography: a new investigational area for cancer research

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Nuclear magnetic resonance spectroscopy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

1 reference

7 January 2021

Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

In vivo detection and imaging of phosphatidylserine expression during programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Magnetic resonance imaging applications in the evaluation of tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

In vivo monitoring of tumor angiogenesis with MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Role of radionuclide imaging in trials of antiangiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Application of CT in the investigation of angiogenesis in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Evaluation of tumor angiogenesis with US: imaging, Doppler, and contrast agents

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

An exciting and challenging role for the advanced contrast MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

MR imaging of tumor microcirculation: promise for the new millennium.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

THE PERMEABILITY OF CAPILLARIES IN VARIOUS ORGANS AS DETERMINED BY USE OF THE 'INDICATOR DIFFUSION' METHOD.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Susceptibility contrast imaging of cerebral blood volume: human experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

NMR imaging of changes in vascular morphology due to tumor angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Contrast agents in functional MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Comparison of Gd- and Dy-chelates for T2* Contrast-Enhanced Imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Contrast-to-noise ratio in functional MRI of relative cerebral blood volume with sprodiamide injection.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Characterization of hepatic lesions by perfusion-weighted MR imaging with an echoplanar sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Differentiating Benign and Malignant Breast Lesions with T2*-Weighted First Pass Perfusion Imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Gliomas: correlation of magnetic susceptibility artifact with histologic grade.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Physiologic measurements by contrast-enhanced MR imaging: expectations and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Key factors in the acquisition of contrast kinetic data for oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Improving image quality and T(1) measurements using saturation recovery turboFLASH with an approximate K-space normalisation filter

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Modeling tracer kinetics in dynamic Gd-DTPA MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Microvessel density in invasive breast cancer assessed by dynamic gd-dtpa enhanced MRI

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Pathophysiologic basis of contrast enhancement in breast tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging--parametric "first-pass" images depict tissue vascularization and perfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

MRI of the uterus, uterine cervix, and vagina: diagnostic performance of dynamic contrast-enhanced fast multiplanar gradient-echo imaging in comparison with fast spin-echo T2-weighted pulse imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Contrast-enhanced MRI of the breast after limited surgery and radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Dynamic contrast-enhanced subtraction versus T2-weighted spin-echo MR imaging in the follow-up of colorectal neoplasm: a prospective study of 41 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Quantitative dynamic contrast enhanced MRI of recurrent pelvic masses in patients treated for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

The pelvis after surgery and radio-chemotherapy for rectal cancer studied with Gd-DTPA-enhanced fast dynamic MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: preliminary results and implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Semiquantitative assessment of uterine perfusion using first pass dynamic contrast-enhanced MR imaging for patients treated with uterine fibroid embolization

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Assessing tumor angiogenesis using macromolecular MR imaging contrast media.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Microvascular permeability of normal and neoplastic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Transport of molecules across tumor vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

On the characteristics of functional magnetic resonance imaging of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Analysis of subcutaneous angiogenesis by gradient echo magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Quantitative assessment of blood flow, blood volume and blood oxygenation effects in functional magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

Tumour response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

BOLD MRI of human tumor oxygenation during carbogen breathing

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2802%2900388-X

7 January 2021

10.1016/S0959-8049(02)00388-X

Identifiers

DOI

1 reference

5 August 2017

1 reference